Aliso Viejo, Calif. – July 8, 2025 – ViaLase, Inc., a medical technology company pioneering noninvasive femtosecond laser treatments for glaucoma, today announced key changes to its executive leadership team as the company prepares for commercial launch and regulatory approvals in both the United States and Europe. Tibor Juhasz, PhD, founder and former Chief Executive […] The post ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth appeared first on Vialase .